Profile
LFLYW ONC WBA DFTX HROWL HROWM
Company Name Leafly Holdings, Inc. BeOne Medicines Ltd. Walgreens Boots Alliance, Inc. Definium Therapeutics, Inc. Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 11.875% Senior Notes due 2027
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals
Market Cap $299.93K $36.98B $10.37B $1.58B $1.37B $1.34B
Employees 0.20K 11.00K 193.00K 0.07K 0.22K 0.22K
CEO Yoko Miyashita John V. Oyler Timothy C. Wentworth Robert Barrow Mark L. Baum Mark L. Baum
Ratings
LFLYW ONC WBA DFTX HROWL HROWM
Quant Rating Score 2 2 2 1 1 1
Quant Rating Sell Sell Sell Strong Sell Strong Sell Strong Sell
Trading
LFLYW ONC WBA DFTX HROWL HROWM
Last Close $0.004 $376.63 $11.98 - $25.61 $26.03
High 52 $0.03 $377.81 $12.93 - $25.72 $26.95
Low 52 - $175.1 $8.24 - $25.01 $25.85
Price vs. 52 Week High -86.67 % -0.31 % -7.35 % - -0.43 % -3.41 %
Price vs. 52 Week Low 0 % 115.09 % 45.39 % - 2.4 % 0.7 %
Total Return
LFLYW ONC WBA DFTX HROWL HROWM
1 Month Return 0 % 19.03 % 0 % - 0 % 0 %
3 Month Return 2.56 % 17.95 % -0.17 % - 0.55 % -1.33 %
6 Month Return -34.43 % 64.91 % 6.11 % - 1.23 % -0.78 %
9 Month Return -50 % 58 % 8.32 % - 1.13 % -2.87 %
YTD Return -77.65 % 104.69 % 28.4 % - 1.32 % -0.69 %
1 Year Return -86.11 % 0 % 44.51 % - 1.31 % -1.03 %
3 Year Return 0 % 0 % 0 % - 0 % 0 %
5 Year Return 0 % 0 % 0 % - 0 % 0 %
Dividends
LFLYW ONC WBA DFTX HROWL HROWM
Dividend Yield Percentage (TTM) - - - - - -
Dividend Paid and Capex Coverage Ration (TTM) -0.07 % 2.45 % 0.96 % - 0.46 % 0.46 %
Dividend Per Share (TTM) - - - - - -
Payout Ratio (TTM) - - -10.29 % - - -
Growth
LFLYW ONC WBA DFTX HROWL HROWM
Asset Growth -10.06 % 1.99 % -16.14 % 24.77 % 24.77 %
Gross Profit Growth -17.32 % 54.71 % -2.02 % 66.06 % 66.06 %
Revenue Growth -18.01 % 54.96 % 6.17 % 53.32 % 53.32 %
Revenue 3 Year -33.56 % 185.46 % 11.65 % 106.71 % 106.71 %
Revenue 5 Year -4.92 % 407.52 % 31.29 % 177.12 % 177.12 %
Revenue 10 Year -4.92 % 14520 % 113.45 % 2980.55 % 2980.55 %
EBIT Growth 51.9 % 52.95 % -183.88 % 1018.99 % 1018.99 %
Net Income Growth 39.49 % 26.87 % -180.39 % 28.39 % 28.39 %
Net Income 3 Yeari Growth Per Share 60.55 % 61.02 % -440.4 % 27.14 % 27.14 %
Net Income 5 Yeari Growth Per Share 85.15 % 61.23 % -331.55 % -7491.01 % -7491.01 %
Net Income 10 Yeari Growth Per Share 85.15 % -1664.38 % -593.61 % 55.74 % 55.74 %
Operating Income Growth 55.52 % 52.95 % -104.53 % 1946.87 % 1946.87 %
Operating Cash Flow Growth (CFG) 115.4 % 87.85 % -54.92 % -678.18 % -678.18 %
Operating 3 Year CFG 115.97 % 90.46 % -81.64 % -427.89 % -427.89 %
Operating 5 Year CFG 103.8 % 89.31 % -80.57 % -1760.03 % -1760.03 %
Operating 10 Year CFG 103.8 % -709.03 % -71.12 % 19.39 % 19.39 %
EPS Growth 51.48 % 27.57 % -180.39 % 34.67 % 34.67 %
EPS Diluted Growth 51.48 % 27.57 % -180.39 % 34.67 % 34.67 %
Book Value Per Share 2.76 % -6.6 % -57.24 % -9.43 % -9.43 %
Share Holder 3 Year Equity Growth Per Share -45.47 % -52.12 % -56.07 % 363.19 % 363.19 %
Share Holder 5 Year Equity Growth Per Share -140.46 % 97.53 % -53.83 % 78.54 % 78.54 %
Share Holder 10 Year Equity Growth Per Share -140.46 % 6367.84 % -43.9 % 118.93 % 118.93 %
Dividend Per Share Growth - - -24.04 % - -
Dividend 3 Year Growth Per Share - - -21.92 % -100 % -100 %
Dividend 5 Year Growth Per Share - - -18.12 % - -
Dividend 10 Year Growth Per Share - - 16.05 % - -
Debt Growth 1 % 16.09 % 0.7 % 20.12 % 20.12 %
Free Cash Flow Growth 98.59 % 61.81 % -357.45 % 59.06 % 59.06 %
Updated On 31 Dec 2024 31 Dec 2024 31 Aug 2024 31 Dec 2024 31 Dec 2024
Profitability
LFLYW ONC WBA DFTX HROWL HROWM
Gross Profit Margin TTM 89.72 % 86.11 % 17.13 % - 74.56 % 74.56 %
Return on Assets TTM -27.6 % 1.06 % -9.07 % -70.95 % -1.37 % -1.37 %
Return on Equity TTM 25.07 % 2.19 % -70.17 % -86.18 % -8.96 % -8.96 %
Return on Capital Employed TTM 11.93 % 3.06 % -7.17 % -88.16 % 9.35 % 9.35 %
Net Income Per EBT TTM 100 % 39.97 % 107.6 % 100 % 90.66 % 90.66 %
EBT Per Ebit TTM 194.96 % 125.31 % 187.84 % 111.18 % -19.78 % -19.78 %
EBIT Per Revenue TTM -8.01 % 3.2 % -2.02 % - 11.13 % 11.13 %
Cash Flow To Debt Ratio TTM -0.32 % 77 % 5.43 % -282.12 % 7.02 % 7.02 %
Receivables Turnover TTM 16.74 5.83 23.42 - 3.21 3.21
Payables Turnover TTM 2.17 1.82 9.41 - 3.35 3.35
Inventory Turnover TTM - 1.31 17.5 - 4.96 4.96
Fixed Asset Turnover TTM 981.91 % 284.64 % 556.84 % - 2202.82 % 2202.82 %
Asset Turnover TTM 176.73 % 65.95 % 222.72 % - 68.87 % 68.87 %
Operating Cash Flow Per Share TTM -0.03 7.13 1.82 -1.33 0.48 0.48
Free Cash Flow Per Share TTM -0.43 4.22 0.67 -1.33 -0.55 -0.55
Cash Per Share TTM 284.93 % 3662.7 % 95.96 % 243.43 % 200 % 200 %
Operating Cash Flow Sales Ratio TTM -0.34 % 15.6 % 1.02 % - 7.07 % 7.07 %
Free Cash Flow Operating Cash Flow Ratio TTM 1566.27 % 59.15 % 36.78 % 100 % -115.84 % -115.84 %
Cash Flow Coverage Ratios TTM -0.32 % 77 % 5.43 % -282.12 % 7.02 % 7.02 %
Price To Free Cash Flows Ratio TTM -88.38 91.17 17.88 -13.85 -86.31 -85.24
Price To Operating Cash Flows Ratio TTM -1351.61 5.68 6.57 -12.23 100.27 99.03
Price Cash Flow Ratio TTM -1351.61 5.68 6.57 -12.23 100.27 99.03
Income Statement (TTM)
LFLYW ONC WBA DFTX HROWL HROWM
Revenue $0.03B $3.81B $147.66B $0B $0.2B $0.2B
Gross Profit $0.03B $3.22B $26.52B $-0B $0.15B $0.15B
Gross Profit Ratio 89.39% 84.41% 17.96% 0% 75.33% 75.33%
EBITDA $-0B $-0.4B $-11.28B $-0.11B $0.02B $0.02B
Net Income $-0.01B $-0.64B $-8.64B $-0.11B $-0.02B $-0.02B
EPS Diluted -2.3 -6.12 -10.01 -0.15 -0.49 -0.49
Balance Sheet (MRQ)
LFLYW ONC WBA DFTX HROWL HROWM
Long Term Debt $0B $0.21B $29.88B $0.02B $0.23B $0.23B
Total Liabilities $0.03B $2.59B $68.86B $0.06B $0.32B $0.32B
Total Equity $-0.02B $3.33B $12.18B $0.24B $0.07B $0.07B
Total Investments $0B $0.13B $4.06B $0B $0B $0B
Total Debt $0.03B $1.08B $33.77B $0.02B $0.23B $0.23B
Total Assets $0.02B $5.92B $81.04B $0.3B $0.39B $0.39B
Cash Flow Statement (TTM)
LFLYW ONC WBA DFTX HROWL HROWM
Net Income $-0.01B $-0.64B $-15.45B $-0.11B $-0.02B $-0.02B
Inventory $0B $-0.09B $-0.03B $0B $0B $0B
Dividends Paid $0B $0B $-1.26B $0B $0B $0B
Operating Cash Flow $0B $-0.14B $1.02B $-0.08B $-0.02B $-0.02B
Capital Expenditure $-0B $-0.53B $-1.38B $0B $-0.04B $-0.04B
Related Stocks
Ticker Name Price
AIXC Qualigen Therapeutics, Inc. 1.3
ATAI Atai Life Sciences N.V. 3.57
ATNFW CannBioRx Life Sciences Corp. 0.43
BGMS Bio Green Med Solution, Inc. 0.9806
BGMSP Bio Green Med Solution, Inc. 3.79
BIMI BIMI International Medical Inc. 0.0001
CGEM Cullinan Oncology, Inc. 11.59
CJJD China Jo-Jo Drugstores, Inc. 1.52
DFTX Mind Medicine (MindMed) Inc. 15.75
HITI High Tide Inc. 2.31
HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares 0.799
HROWL Harrow Health, Inc. 8.625% Senior Notes due 2026 25.61
HROWM Harrow Health, Inc. 11.875% Senior Notes due 2027 26.03
KYNB FibroGen, Inc. 7.45
LFLY Leafly Holdings, Inc. 37
LFMD LifeMD, Inc. 2.78
LFMDP LifeMD, Inc. 22.5
MDVL MedAvail Holdings, Inc. 1.8
MEDS TRxADE HEALTH, Inc. 7.59
MSLE Satellos Bioscience Inc. Common Stock 11.5
Unlock